Näytä suppeat kuvailutiedot

Rasvamaksan biomarkkeriaineisto hankkeesta Personoitu ravitsemusinterventio rasvamaksan hoitamiseksi

dc.contributor.authorPietiläinen, Kirsi H.
dc.contributor.authorMäkinen, Elina
dc.contributor.authorLensu, Sanna
dc.contributor.authorLaukkanen, Jari A.
dc.contributor.authorHakkarainen, Antti
dc.contributor.authorKuula, Juho
dc.contributor.authorJuvonen, Risto
dc.contributor.authorO’Connell, Thomas
dc.contributor.authorKeski-Rahkonen, Pekka
dc.contributor.authorLehtonen, Marko
dc.contributor.authorPekkala, Satu
dc.contributor.authorHintikka, Jukka
dc.contributor.otherHelsingin yliopisto
dc.contributor.otherPietiläinen, Kirsi H.
dc.contributor.otherUniversity of Jyväskylä
dc.contributor.otherUniversity of Eastern Finland
dc.contributor.otherHospital District of Helsinki and Uusimaa
dc.contributor.otherUniversity of Helsinki
dc.contributor.otherJyväskylän yliopisto
dc.contributor.otherItä-Suomen yliopisto (ISY)
dc.contributor.otherHelsingin ja Uudenmaan sairaanhoitopiiri
dc.date.accessioned2023-01-18T08:50:02Z
dc.date.available2023-01-18T08:50:02Z
dc.date.issued2023
dc.identifier.citationAnastasiia Driuchina; Jukka Hintikka; Marko Lehtonen; Pekka Keski-Rahkonen; Thomas O’Connell; Risto Juvonen; Juho Kuula; Antti Hakkarainen; Jari A. Laukkanen; Elina Mäkinen; Sanna Lensu et al. (2023). Liver fat biomarkers study from the 'Personalized diet intervention to treat fatty liver' project. 10.17011/jyx/dataset/85068
dc.identifier.otherjyu-resd.172576021
dc.identifier.urihttps://jyx.jyu.fi/handle/123456789/85068
dc.description.abstractThe study aimed at finding gut microbiota signatures and metabolite markers in plasma and feces related to high liver fat content in humans. Based on imaging, we divided study participants into low (<5%, LF, n=25) and high (>5%, HF, n=39) liver fat groups. Fecal (LF n=14, HF n=25) and plasma (LF n=11, HF n=7) metabolomes of subsets of participants were studied using liquid chromatography/high resolution mass spectrometry. The gut microbiota were analyzed using 16S rRNA gene sequencing. Additionally, blood clinical variables, body composition and diet were studied. The list of metadata variables can be found below. They are categorized by the type of sample and/or analysis. BLOOD CLINICAL VARIABLES & UNITS alanine aminotransferase, ALT (U/L) aspartate aminotransferase, AST (U/L) gamma-glutamyltransferase, GGT(U/L) total cholesterol (mmol/L) high-density lipoprotein, HDL (mmol/L) low-density lipoprotein, LDL (mmol/L) triglycrides (mmol/L) glucose (mmol/L) insulin (iU/L) HOMA-IR BODY COMPOSITION VARIABLES & UNITS Height (cm) Weight (kg) body mass index, BMI (kg/m2) Waist circumference (cm) blood pressure (BP) systolic (mm Hg) blood pressure (BP) diastolic (mm Hg) Liver fat % GUT MICROBIOTA COMPOSITION fastq files of the sequences OUT counts per each sample relative abundance per each sample diversity measures (Shannon, Chao1, phylogenetic diversity, Bray Curtis distance) METABOLITES plasma metabolites & identification information fecal metabolites & identification information DIETARY INTAKES & UNITS (from 3 different days & average from 3 days) Energy (kJ) Energy (kcal) Protein (g) Carbohydrates (g) Fat (g) Alcohol Coffee (dl/3 days) * Fatty acids (g) Monosaturated Fatty acids (g) Polyunsaturated Fatty acids (g) Sucrose (g) Fiber, total (g) Vitamin C (mg) Thiamine (B1) (mg) Vitamin E (mg) Vitamin A (µg) Vitamin D (µg) Riboflavin (B2) (mg) Vitamin K (mg) Vitamin B6 (mg) Folate (B9) (µg) Sodium (mg) Magnesium (mg) Calcium (mg) Potassium (mg) Iron (mg) Iodine (µg) Phosphorus (mg) Selenium (µg) Zinc (mg) Fatty acids, total (g) Cholesterol (mg) Fatty acids, trans (g) Lactose (g) Fiber, total amount (g) Vitamin B12 (cobalamine) (µg) Salt (mg) Omega-6 Fatty acids (g) Omega-3 Fatty acids (g).en
dc.language.isoeng
dc.rightsIn Copyright
dc.titleLiver fat biomarkers study from the 'Personalized diet intervention to treat fatty liver' projecten
dc.titleRasvamaksan biomarkkeriaineisto hankkeesta Personoitu ravitsemusinterventio rasvamaksan hoitamiseksifi
dc.typedataset
dc.identifier.urnURN:NBN:fi:jyu-202301181370
dc.contributor.tiedekuntaLiikuntatieteellinen tiedekunta
dc.contributor.tiedekuntaKasvatustieteiden ja psykologian tiedekuntafi
dc.contributor.tiedekuntaFaculty of Education and Psychologyen
dc.contributor.tiedekuntaFaculty of Sport and Health Sciences
dc.contributor.laitosTerveystieteiden laitosfi
dc.contributor.laitosDepartment of Psychologyen
dc.contributor.laitosDepartment of Health Sciencesen
dc.contributor.laitosPsykologian laitosfi
dc.contributor.yliopistoJyväskylän yliopistofi
dc.contributor.yliopistoUniversity of Jyväskyläen
dc.type.urihttp://purl.org/coar/resource_type/c_ddb1
dc.identifier.doi10.17011/jyx/dataset/85068
dc.rights.copyrightPekkala, Satu and University of Jyväskylä
dc.rights.accesslevelrestrictedAccess
dc.relation.grantnumber308042
dc.subject.ysometabolismen
dc.subject.ysomicrobiologyen
dc.subject.ysoinsulin resistanceen
dc.subject.ysofatty liveren
dc.subject.ysorasvamaksafi
dc.subject.ysoaineenvaihduntafi
dc.subject.ysomikrobiologiafi
dc.subject.ysoinsuliiniresistenssifi
jyx.subject.urihttp://www.yso.fi/onto/yso/p22290
jyx.subject.urihttp://www.yso.fi/onto/yso/p3066
jyx.subject.urihttp://www.yso.fi/onto/yso/p13507
jyx.subject.urihttp://www.yso.fi/onto/yso/p21481
dc.rights.urlhttps://rightsstatements.org/page/InC/1.0/
dc.rights.accessrightsRestricted use due to personal information protection. You can still contact author to ask for a copy of the material.
dc.relation.funderAcademy of Finland
dc.relation.funderSuomen Akatemia
jyx.fundingprogramAcademy Research Fellow, AoF
jyx.fundingprogramAkatemiatutkija, SA


Aineistoon kuuluvat tiedostot

TiedostotKokoTiedostomuotoKatso

Aineistoon ei liity tiedostoja.

Aineisto kuuluu seuraaviin kokoelmiin

Näytä suppeat kuvailutiedot

In Copyright
Ellei muuten mainita, aineiston lisenssi on In Copyright